SpeedWeed

JULY 8, 2021

We categorize a license as a manufacturer if it fits the following description: License is for the processing (manufacturing) of marijuana-infused products, such as edibles or concentrates, but does not include cultivation or retail sale to customers (flower in, product out). States are rarely in harmony when it comes to these licenses.

Media 52

Media Data Retail Concentrates 52

Meadow

DECEMBER 24, 2017

And then you see the consumption version of that, where folks would be sold a small amount of cannabis or concentrate that they could use on site. One part of the Type 9 creation that’s important is it’s exempt from the public access provisions. We’ve had this debate here in San Francisco about what does over-concentration look like.

Packaging 40

Packaging Retail Edibles Wellness and Beauty 40

Meadow

JULY 13, 2018

we want everyone who did not have the opportunity to attend Meadowlands to have access to this content. So yeah, communication, listening to the people that are on the frontlines, the people that are doing the demos. So please feel free to share this post with your network and your community?—?we

Supply Chain 40

Supply Chain Compliance Compliance Cannabis 40

SpeedWeed

JULY 27, 2021

NORML offers a robust State Laws section on its website where laws in all 50 states can be accessed by clicking on each state on the U.S. Schedule a demo and see how it can help you build your business by connecting with license holders who need the products and services you supply. View original article.

Law 52

Law Policy Data Programs 52

Cannabis Law Report

JULY 9, 2021

Membership offers access to premium cannabis brands for up to 50% less . A major facet in the vibrant market for concentrates and extracts for producers and consumers alike is the obsession with quality and efficiency. Airgraft, Inc. , Mladen Barbaric is a recognized leader and innovator in product design and technology.

Programs 98

Programs Extraction Oil Access 98

Cannabis Law Report

SEPTEMBER 19, 2019

Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. Yet, access to legal medicinal marijuana remains extremely limited. policy, and?could prominently?in

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40